by Team Small News | Dec 30, 2025 | Dr Reddy's
The Delhi High Court has issued a restraining order against Dr. Reddy’s Laboratories, preventing the company from using the ‘SUN’ mark on their sunscreen product labels. This decision comes after a lawsuit was filed by Sun Pharmaceutical Industries,...
by Team Small News | Dec 27, 2025 | Dr Reddy's
An error occurred during the execution of a web request, resulting in an unhandled exception. The exception was a System.FormatException, which indicates that the input string was not in the correct format. This error occurred in the Page_Load method of the...
by Team Small News | Dec 25, 2025 | Dr Reddy's
A new sign has been erected at the former Dr. Reddy’s plant in Shreveport, indicating that Frymaster, a commercial fryer manufacturer, will be occupying the space. This development marks a significant turning point for the facility, which was previously home to...
by Team Small News | Dec 14, 2025 | Dr Reddy's
The US Food and Drug Administration (FDA) has approved two new oral medicines, Nuzolvence (zoliflodacin) and Blujepa (gepotidacin), to treat gonorrhea, a common sexually transmitted infection (STI) that is increasingly resistant to existing treatments. The World...
by Team Small News | Dec 9, 2025 | Dr Reddy's
Dr. Reddy’s Laboratories and Immutep Limited have formed a strategic partnership to develop and commercialize Eftilagimod alfa, a novel immunotherapy treatment. The partnership aims to accelerate the development and availability of this promising therapy for...
by Team Small News | Dec 5, 2025 | Dr Reddy's
An Indian court has ruled in favor of Dr. Reddy’s Laboratories, allowing the company to manufacture and export generic versions of Novo Nordisk’s popular diabetes and weight-loss medications, Ozempic and Wegovy. The key ingredient in these drugs is...